文献速递胃肠动力与功能性疾病

血清脂质组学揭示胆汁酸腹泻的诊断潜力

Serum lipidome unravels a diagnostic potential in bile acid diarrhoea.
PubMed 文献 · Gut · 2023-04-18

研究纳入50例经金标准75硒同牛磺胆酸试验诊断的初治胆汁酸腹泻患者、56例特征匹配对照和37例非酒精性脂肪性肝病患者,用质谱检测1295种代谢物并开发机器学习诊断评分。基于5种代谢物浓度的逻辑回归模型区分胆汁酸腹泻与对照的灵敏度为0.78(95% CI 0.64至0.89),特异度为0.93(95% CI 0.83至0.98),且优于目前开发中的其他血液检测。

要点

  • 胆汁酸腹泻患者血清代谢组与对照及非酒精性脂肪性肝病患者显著不同。
  • 基于5种代谢物的胆汁酸腹泻诊断评分灵敏度0.78、特异度0.93。
  • 该评分优于目前开发中的7α-羟基-4-胆甾烯-3-酮和成纤维细胞生长因子19血液检测。

核心结论

  • 基于单份血清代谢物开发的胆汁酸腹泻诊断评分能稳健识别胆汁酸腹泻患者,其特异度和灵敏度优于当前基于血液检测的诊断方法。

研究设计与样本

  • 研究纳入50例经金标准75硒同牛磺胆酸试验诊断的初治胆汁酸腹泻患者、56例特征匹配对照和37例非酒精性脂肪性肝病患者的血清。
  • 使用质谱生成覆盖1295种代谢物的代谢组并在组间比较,采用机器学习开发胆汁酸腹泻诊断评分。

主要发现

  • 胆汁酸腹泻患者的代谢组与对照和非酒精性脂肪性肝病患者显著不同。
  • 在发现集中检测到70种代谢物的判别性能受试者工作特征曲线下面积大于0.80。
  • 使用癸酰肉碱、胆固醇酯(22:5)、二十碳三烯酸、L-α-溶血磷脂酰肌醇(18:0)和磷脂酰乙醇胺(O-16:0/18:1)浓度的逻辑回归模型区分胆汁酸腹泻与对照的灵敏度为0.78(95% CI 0.64至0.89),特异度为0.93(95% CI 0.83至0.98)。
  • 该模型独立于年龄、性别和体重指数等协变量,并能区分胆汁酸腹泻与非酒精性脂肪性肝病,与纤维化分期无关。
  • 胆汁酸腹泻诊断评分优于目前开发中的其他血液检测(7α-羟基-4-胆甾烯-3-酮和成纤维细胞生长因子19)。

关键数值与推荐

  • 逻辑回归模型区分胆汁酸腹泻与对照的灵敏度为0.78(95% CI 0.64至0.89),特异度为0.93(95% CI 0.83至0.98)。
  • 发现集中有70种代谢物的受试者工作特征曲线下面积大于0.80。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Bile acid diarrhoea (BAD) is debilitating yet treatable, but it remains underdiagnosed due to challenging diagnostics. We developed a blood test-based method to guide BAD diagnosis. DESIGN: We included serum from 50 treatment-naive patients with BAD diagnosed by gold standard 75selenium homotaurocholic acid test, 56 feature-matched controls and 37 patients with non-alcoholic fatty liver disease (NAFLD). Metabolomes were generated using mass spectrometry covering 1295 metabolites and compared between groups. Machine learning was used to develop a BAD Diagnostic Score (BDS). RESULTS: Metabolomes of patients with BAD significantly differed from controls and NAFLD. We detected 70 metabolites with a discriminatory performance in the discovery set with an area under receiver-operating curve metric above 0.80. Logistic regression modelling using concentrations of decanoylcarnitine, cholesterol ester (22:5), eicosatrienoic acid, L-alpha-lysophosphatidylinositol (18:0) and phosphatidylethanolamine (O-16:0/18:1) distinguished BAD from controls with a sensitivity of 0.78 (95% CI 0.64 to 0.89) and a specificity of 0.93 (95% CI 0.83 to 0.98). The model was independent of covariates (age, sex, body mass index) and distinguished BAD from NAFLD irrespective of fibrosis stage. BDS outperformed other blood test-based tests (7-alpha-hydroxy-4-cholesten-3-one and fibroblast growth factor 19) currently under development. CONCLUSIONS: BDS derived from serum metabolites in a single-blood sample showed robust identification of patients with BAD with superior specificity and sensitivity compared with current blood test-based diagnostics.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Lewinska M, Kårhus ML, Ellegaard AG, et al. Serum lipidome unravels a diagnostic potential in bile acid diarrhoea. Gut. 2023. PMID: 37072179. doi:10.1136/gutjnl-2022-329213

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。